Cingulate signs agreement to market its first drug candidate
Cingulate Inc. announced Monday a big step, on the business side, toward rolling out its first drug.
The Kansas City, Kansas, company (Nasdaq:CING) announced a joint commercialization agreement with Indegene. The companies will work to bring to market Cingulate ’s first drug candidate. The drug, CTx-1301, is billed as a once-daily medication to treat attention deficit/hyperactivity disorder (ADHD) — a market Cingulate estimates at $20 billion.
Cingulate expects results from a Phase 3 trial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 13, 2023 Category: Pharmaceuticals Authors: Brian Kaberline Source Type: news
How does attention deficit hyperactivity disorder affect children's road-crossing? A case-control study - Tabibi Z, Schwebel DC, Juzdani MH.
OBJECTIVE: Children diagnosed with attention-deficit/hyperactivity disorder (ADHD) may have particularly high pedestrian injury risk given their deficits in attention, inhibition, and concentration. The aims of this study were a) to assess differences in p... (Source: SafetyLit)
Source: SafetyLit - March 9, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Glenmark and Cediprof announce exclusive distribution agreement in US
Glenmark Pharmaceuticals on Thursday said it has entered into an exclusive agreement with Cediprof Inc for supply and distribution in the US for the latter's generic drug indicated for the treatment of attention deficit hyperactivity disorder. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2023 Category: Pharmaceuticals Source Type: news
Forget Adderall: Children who exercise have lower risk of ADHD and behavioral problems
Scientists in the UK and US say they found youngsters who did regular moderate and vigorous exercise had reduced hyperactivity and behavioral problems. (Source: the Mail online | Health)
Source: the Mail online | Health - March 1, 2023 Category: Consumer Health News Source Type: news
Op-ed: DEA and FDA rules exacerbate Adderall shortage
Josh Disbrow is chairman and chief executive officer of Aytu BioPharma, which makes a competing drug to treat ADHD called Adzenys XR-ODT. A nationwide shortage of Adderall has left many patients struggling to manage their attention deficit hyperactivity disorder, better known as ADHD. From all…#joshdisbrow #aytubiopharma #adzenysxrodt #adderall #scheduleii #dea #adderallxr #fda (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2023 Category: Consumer Health News Source Type: news
ADHD Med Exposure in Utero Not Tied to Long-Term Impact in Offspring
FRIDAY, Feb. 24, 2023 -- Neurodevelopment and growth in offspring is not negatively impacted by prenatal exposure to attention-deficit/hyperactivity disorder (ADHD) medication, according to a study published online Feb. 9 in Molecular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 24, 2023 Category: Pharmaceuticals Source Type: news
Predictors of risky driving among teen drivers with ADHD during U.S. COVID-19 shelter in place orders - Garner AA, Epstein JN, Tamm L, Simon JO, Fisher DL, Kiefer AW, MacPherson RP.
Factors associated with continued driving during shelter in place orders have been examined in a community sample of typically developing teen drivers, but not in teens diagnosed with Attention/Deficit-Hyperactivity Disorder (ADHD). Our objective was to ex... (Source: SafetyLit)
Source: SafetyLit - February 22, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
' I Run Cuddle Parties To Help People Say No '
In 2008 I was struggling with codependency, attention deficit hyperactivity disorder (ADHD), and emotional issues. I was married and I had two small children. At the time, I was reading a book on relationships and there was a chapter about healthy boundaries. In this book, a cuddle party was…#acuddleparty #cuddleparty #wisconsin #welcomecircle #madelonguinazzo #cuddlepartyinc #cuddlist (Source: Reuters: Health)
Source: Reuters: Health - February 19, 2023 Category: Consumer Health News Source Type: news
Effect of psychostimulant medications on static balance performance in adults with attention deficit hyperactivity disorder: within-subjects repeated-measure study - Alotaibi MM, Motl RW, Stavrinos D, Snyder SW, Singh H, Lein DHJ.
This study examined the effect of psychostimulant medications nPS) on balance and functional motor performance in adults with attention-deficit/hyperactivity disorder (ADHD). METHODS: Participants completed two sessions (off-medication a... (Source: SafetyLit)
Source: SafetyLit - February 15, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
No Sign That ADHD Meds in Pregnancy Can Raise Odds for ADHD, Autism in Kids
TUESDAY, Feb. 14, 2023 -- Children who were exposed to attention deficit hyperactivity disorder (ADHD) medications their moms took during pregnancy are not more prone to neurodevelopmental disorders such as ADHD or autism, researchers report.
The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2023 Category: General Medicine Source Type: news
Are self-reported and parent-reported attention problems and hyperactivity associated with higher rates of concussion in youth ice hockey players? - Gerschman T, Brooks BL, Mrazik M, Eliason PH, Bonfield S, Yeates KO, Emery CA, Schneider KJ.
OBJECTIVE: To examine the association between self-reported and parent-reported attention problems and hyperactivity and rates of injury and concussion in Canadian youth ice hockey players. DESIGN: Secondary analyses of 2 prospective cohort studies... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Thrsp gene and the ADHD predominantly inattentive presentation - Custodio RJP, Kim M, Chung YC, Kim BN, Kim HJ, Cheong JH.
There are three presentations of attention-deficit/hyperactivity disorder (ADHD): the predominantly inattention (ADHD-PI), predominantly hyperactive-impulsive (ADHD-HI), and combined (ADHD-C) presentations of ADHD. These may represent distinct childhood-on... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Ritalin Drug Shortage Explained: Low Supplies Of Adderall And Prescription Startups Fueled Crisis
Ritalin is the latest attention deficit hyperactivity disorder (ADHD) medication in short supply—after a months-long Adderall shortage—leaving patients who rely on these drugs to manage daily symptoms without proper treatment. Shortages of Adderall, a medication used to treat attention deficit…#ritalin #shortagesofadderall #concerta #fda #adderall #tevapharmaceuticals #tevaadderall #alvogen #johnsonjohnson #novartis (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2023 Category: Consumer Health News Source Type: news
Emotional Blunting Explained; 8% of Adults on Sleep Meds; Long Waits for Psych Care
(MedPage Today) -- Emotional "blunting," often seen with use of antidepressants, may stem from the drugs' effects on reinforcement learning, according to a placebo-controlled semi-randomized trial. (Neuropsychopharmacology)
Attention deficit-hyperactivity... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 25, 2023 Category: Psychiatry Source Type: news
ADHD Tied to Higher Rates of Anxiety, Depression
THURSDAY, Jan. 19, 2023 -- Attention-deficit/hyperactivity disorder (ADHD) may be an even bigger predictor of depression and anxiety in adulthood than autism is, a new study finds— highlighting the mental health side of the disorder.
It ' s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 19, 2023 Category: General Medicine Source Type: news
